Welcome to our dedicated page for Lifeway Foods SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods Inc. filings document the regulatory record for an Illinois operating company whose common stock trades on the Nasdaq Global Market under the symbol LWAY. Its Form 8-K reports cover operating results, sales estimates, Regulation FD disclosures, material agreements, director appointments and resignations, and compensatory arrangements under the company's 2022 Omnibus Incentive Plan.
Proxy materials describe annual shareholder meeting matters, board and committee governance, executive compensation and equity-plan administration. The filing record also identifies the company's registered securities, including common stock and preferred stock purchase rights, and includes formal disclosures related to financial reporting, governance changes and capital-structure matters.
Lifeway Foods, Inc. (LWAY) director Juan Carlos Dalto reported equity award activity on August 31, 2026. 1,550 restricted stock units (RSUs) vested and were exchanged for 1,550 shares of phantom stock under the company’s Non-Employee Director Equity and Deferred Compensation Plan, deferring receipt of common shares until he no longer serves as a director. He now holds 4,751 shares of common stock directly, plus phantom stock and several RSU grants that are scheduled to vest on December 30, 2026 and July 1, 2027, contingent on continued board service. No Rule 10b5-1 trading plan is reported.
Lifeway Foods, Inc. (LWAY) director Dorri McWhorter exercised 1,550 Restricted Stock Units into 1,550 shares of Common Stock on August 31, 2026 at $0.00 per share, bringing her directly held common shares to 28,842. She continues to hold several RSU awards that each represent a contingent right to receive one share of common stock, vesting in 2026 and 2027, contingent on continued service as a director; no Rule 10b5-1 trading plan is reported.
Lifeway Foods, Inc. (LWAY) director Jason Scott Scher reported equity compensation-related transactions on August 31, 2026. 1,550 restricted stock units (RSUs) vested and were exchanged for 1,550 shares of phantom stock, deferring receipt of common shares under the company’s Non-Employee Director Equity and Deferred Compensation Plan. Following these transactions, Scher directly holds 84,608 phantom stock units, plus several outstanding RSU awards that may convert into common stock at future vesting dates, and 1 share of common stock. No Rule 10b5-1 trading plan is reported.
Lifeway Foods, Inc. (LWAY) CEO, President and Secretary Julie Smolyansky reported purchasing 2,000 shares of common stock on August 19, 2026 at $25.26 per share in an open-market or private transaction, bringing her directly held common stock position to 2,214,095 shares. She also reports direct and indirect holdings of restricted stock units (RSUs) tied to common stock, with various tranches scheduled to vest in 2027 and 2028 contingent on continued service by her or her spouse, plus additional common shares held for the benefit of minor children, by her spouse, and through Smolyansky Holding LLC.
Divisadero Street Partners, L.P., a private investment fund managed by Divisadero Street Capital Management, LP, reported open-market purchases of Lifeway Foods, Inc. common stock. On August 13, 14, and 17, 2026, the fund bought an aggregate of 246,568 shares at per-share prices around the mid‑$24 range, including weighted-average purchase ranges of $24.5375–$25.4022 and $24.6705–$24.8293. The securities are held by the fund and may be deemed indirectly beneficially owned by related Divisadero entities and William Zolezzi, with all positions reported as indirect ownership. The filing does not indicate that these transactions were made pursuant to a Rule 10b5-1 trading plan.
Lifeway Foods, Inc. major shareholder Edward Smolyansky reported indirect open‑market sales of 110,000 shares of common stock on August 12 and 14, 2026. The shares, held by the Edward Smolyansky Trust 2/2/16, were sold at weighted average prices of $28.74 (35,000 shares), $24.89 (29,931 shares), $25.82 (45,038 shares), and $26.50 (31 shares), with detailed price ranges noted in the footnotes. After these transactions, reported holdings include 100,000 shares held directly and 902,642 shares held by his son, as to which beneficial ownership is disclaimed, plus additional shares held by an LLC where beneficial ownership is also disclaimed. The Rule 10b5‑1 trading plan box was not checked.
Edward Smolyansky filed a notice to sell up to 75,000 shares of LWAY common stock through Citigroup Global Markets Inc., with sales expected on or after 08/14/2026 on NASDAQ. The filing also lists multiple prior sales of LWAY common stock over the past three months, including blocks of 111,548 shares for $3,263,599.87 on 06/26/2026 and 66,916 shares for $2,142,764.08 on 07/15/2026. A prior transfer of 75,000 shares was reported as a gift by Ludmila Smolyansky on 05/19/2023.
Lifeway Foods, Inc. reported strong top-line growth but weaker profitability for the quarter and six months ended June 30, 2026. Net sales rose to $66.9M for the quarter, up 24.1% year over year, and to $129.9M for the first half, a 29.9% increase, primarily from higher volumes of branded drinkable kefir.
Profitability contracted as gross margin fell to 19.5% from 28.6% in the quarter and to 23.4% from 26.5% year to date, driven mainly by higher conventional milk prices and, to a lesser extent, higher resin-based packaging and transportation costs. Quarterly net income declined to $0.1M (basic EPS $0.01) from $4.2M, while six‑month net income decreased to $4.8M from $7.8M.
The company is investing heavily in capacity, with $19.5M of capital expenditures in the first half and an estimated $50.5M project to expand and modernize its Waukesha, Wisconsin plant, expected to double manufacturing capacity. To support this, Lifeway drew $22.0M on its $25.0M revolving credit facility and put in place a $22.0M Interim Funding Agreement for equipment financing, while ending the period with $7.1M in cash and remaining covenant compliant.
Lifeway Foods reported record second-quarter 2026 net sales of $66.9 million, up 24.1% year-over-year and surpassing its prior quarterly record by $3.9 million. This marked the company’s 27th consecutive quarter of year-over-year net sales growth. First-half 2026 net sales were $129.9 million, up 29.9% from the prior-year period.
Strong top-line growth was offset by higher input costs. Gross profit margin fell to 19.5% from 28.6% in the quarter, primarily due to elevated milk prices and higher resin and transportation costs. Quarterly net income declined to $0.1 million ($0.01 per share) from $4.3 million ($0.28 per share). For the first half, net income was $4.8 million versus $7.8 million a year earlier.
The company continued to invest heavily in capacity and growth. Property, plant and equipment, net, increased to $65.6 million from $48.3 million at year-end 2025, supported by $19.5 million in capital spending and new borrowings under a $23.0 million line of credit, with $21.9 million outstanding. Lifeway also repurchased $4.9 million of treasury stock. Management highlighted ongoing distribution gains, brand activations and a planned Waukesha facility expansion, and stated an expectation that gross margin and profitability will fully recover in 2027 as milk costs ease and operational efficiencies materialize.
Edward Smolyansky filed a notice to sell 35,000 shares of Lifeway Foods (LWAY) common stock through Citigroup Global Markets Inc. The proposed aggregate sale price is $1,005,781.00, with the transaction expected on August 12, 2026 on NASDAQ. The filing also lists multiple prior sales of LWAY common stock over the past three months, including several large blocks exceeding 50,000 shares each.